Journal of Parkinson's Disease and Movement Disorders

The molecular and genetic view of tauopathies: From structural polymorphism to systemic neurodegeneration

Esra Demir Ünal, Selim Selçuk Çomoğlu

DOI: 10.5606/phhb.dergisi.2026.66

Issue: 2026, Volume 29 - Issue 2
690 563

Sleep disturbances and their clinical correlates in patients with hemifacial spasm

Özge Gönül Öner, Gözde Baran

DOI: 10.5606/phhb.dergisi.2026.79

Issue: 2026, Volume 29 - Issue 2
566 520

Candidate profile and clinical characteristics of patients undergoing STN-DBS surgery for advanced Parkinson's disease: A single-center experience

Gülce Coşku Yılmaz Çakan, Gökhan Gürkan, Ali Akay, Özge Yılmaz Küsbeci

DOI: 10.5606/phhb.dergisi.2026.71

Issue: 2026, Volume 29 - Issue 2
479 459

Comparison of botulinum toxin type A administered at different dilutions in patients with clonic hemifacial spasm

Hanife Şentürk, İlknur Güçlü Altun, Banu Özen Barut

DOI: 10.5606/phhb.dergisi.2026.77

Issue: 2026, Volume 29 - Issue 2
476 429

Comparative evaluation of neuropsychiatric and psychometric parameters in patients with functional movement disorder

Miray Erdem, Elif Banu Söker, Şencan Buturak, Mehmet Balal

DOI: 10.5606/phhb.dergisi.2026.81

Issue: 2026, Volume 29 - Issue 2
390 438

Sydenham's chorea exacerbated in late adulthood: A rare case report

Meral Öksüz, Zehra Yavuz, Özlem Bizpınar Munis, Selim Selçuk Çomoğlu

DOI: 10.5606/phhb.dergisi.2026.37

Issue: 2026, Volume 29 - Issue 2
413 414

Acetazolamide-associated lingual myokymia: A reversible peripheral nerve hyperexcitability phenotype

Esra Demir Ünal, Nur Dilara Çağman

DOI: 10.5606/phhb.dergisi.2026.62

Issue: 2026, Volume 29 - Issue 2
530 474